Id-1 expression promotes cell survival through activation of NF-κB signalling pathway in prostate cancer cells

Oncogene

Volumn 22, Issue 29, 2003, Pages 4498-4508

  Ling, Ming Tat ^a   Wang, Xianghong ^a   Ouyang, Xue Song ^a,c   Xu, Kexin ^a,d   Tsao, Sai Wah ^a   Wong, Yong Chuan ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d People's Hospital   (China)

Author keywords

Apoptosis; Id 1; NF B; Prostate cancer; TNF

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CASPASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF DIFFERENTIATION 1; INTERCELLULAR ADHESION MOLECULE 1; PROTEIN; PROTEIN BAX; PROTEIN BCL XL; PROTEIN P50; SYNAPTOTAGMIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN TRANSPORT; SENSITIZATION; SIGNAL TRANSDUCTION; TRANSACTIVATION;

ADENOCARCINOMA; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CASPASE 3; CASPASES; CELL NUCLEUS; CELL SURVIVAL; GENE EXPRESSION REGULATION; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 1; INTERCELLULAR ADHESION MOLECULE-1; MALE; NF-KAPPA B; OLIGONUCLEOTIDES, ANTISENSE; POLY(ADP-RIBOSE) POLYMERASES; PROSTATIC NEOPLASMS; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0043170868     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206693     Document Type: Article

References (52)

1. Alani RM, Hasskarl J, Grace M, Hernandez MC, Israel MA and Munger K. (1999). Proc. Natl. Acad. Sci. USA, 96, 9637-9641.
2. Alani RM, Young AZ and Shifflett CB. (2001). Proc. Natl. Acad. Sci. USA, 98, 7812-7816.
3. Baeuerle PA and Baltimore D. (1996). Cell, 87, 13-20.
4. Baldwin Jr AS. (1996). Annu. Rev. Immunol., 14, 649-683 .
5. Baldwin Jr AS, Azizkhan JC, Jensen DE, Beg AA and Coodly LR. (1991). Mol. Cell. Biol., 11, 4943-4951.
6. Barone MV, Pepperkok R, Peverali FA and Philipson L. (1994). Proc. Natl. Acad. Sci. USA, 91, 4985-4988.
7. Benezra R, Davis RL, Lockshon D, Turner DL and Weintraub H. (1990). Cell, 61, 49-59.
8. Chen F, Castranova V and Shi X. (2001). Am. J. Pathol., 159, 387-397.
9. Desprez PY, Hara E, Bissell MJ and Campisi J. (1995). Mol Cell. Biol., 15, 3398-3404.
10. Desprez PY, Lin CQ, Thomasset N, Sympson CJ, Bissell MJ and Campisi J. (1998). Mol. Cell. Biol., 18, 4577-4588.
11. Dhanalakshmi S, Singh RP, Agarwal C and Agarwal R. (2002). Oncogene, 21, 1759-1767.
12. DiDonato J, Mercurio F, Rosette C, Wu-Li J, Suyang H, Ghosh S and Karin M. (1996). Mol. Cell. Biol., 16, 1295-1304.
13. Gupta S, Afaq F and Mukhtar H. (2002). Oncogene, 21, 3727-3738.
14. Gurumurthy S, Vasudevan KM and Rangnekar VM. (2001). Cancer Metastasis Rev., 20, 225-243.
15. Florio M, Hernandez MC, Yang H, Shu HK, Cleveland JL and Israel MA. (1998). Mol. Cell. Biol., 18, 5435-5444.
16. Hara E, Uzman JA, Dimri GP, Nehlin JO, Testori A and Campisi J. (1996). Dev. Genet., 18, 161-172.
17. Hara E, Yamaguchi T, Nojima H, Ide T, Campisi J, Okayama H and Oda K. (1994). J. Biol. Chem., 269, 2139-2145.
18. Huang S, Pettaway CA, Uehara H, Bucana CD and Fidler IJ. (2001). Oncogene, 20, 4188-4197.
19. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE and Poirier GG. (1993). Cancer Res., 53, 3976-3985.
20. Kebebew E, Treseler PA, Duh QY and Clark OH. (2000). Surgery, 128, 952-957.
21. Kim BY, Gaynor RB, Song K, Dritschilo A and Jung M. (2002a). Oncogene, 21, 4490-4497.
22. Kim D, Xu M, Nie L, Peng XC, Jimi E, Voll RE, Nguyen T, Ghosh S and Sun XH. (2002b). Immunity, 16, 9-21.
23. Kleeff J, Ishiwata T, Friess H, Buchler MW, Israel MA and Korc M. (1998). Cancer Res., 58, 3769-3772.
24. Langlands K, Down GA and Kealey T. (2000). Cancer Res., 60, 5929-5933.
25. Li X and Stark GR. (2002). Exp. Hematol., 30, 285-296.
26. Lin CQ, Singh J, Murata K, Itahana Y, Parrinello S, Liang SH, Gillett CE, Campisi J and Desprez PY. (2000). Cancer Res., 60, 1332-1340.
27. Ling MT, Wang X, Tsao SW and Wong YC. (2002a). Biochim. Biophys. Acta, 1570, 145-152.
28. Ling MT, Wang X, Ouyang X, Lee TKW, Fan T, Xu K, Tsao SW and Wong YC. (2002b). Oncogene, 21, 8498-8505.
29. Lyden D, Young AZ, Zagzag D, Yan W, Gerald W, O'Reilly R, Bader BL, Hynes RO, Zhuang Y, Manova K and Benezra R. (1999). Nature, 401, 670-677.
30. Madrid LV, Wang CY, Guttridge DC, Schottelius AJ, Baldwin Jr AS and Mayo MW. (2000). Mol. Cell. Biol., 20, 1626-1638.
31. Maruyama H, Kleeff J, Wildi S, Friess H, Buchler MW, Israel MA and Korc M. (1999). Am. J. Pathol., 155, 815-822.
32. Norton JD and Atherton GT. (1998). Mol. Cell. Biol., 18, 2371-2381.
33. Ohtani N, Zebedee Z, Huot TJ, Stinson JA, Sugimoto M, Ohashi Y, Sharrocks AD, Peters G and Hara E. (2001). Nature, 409, 1067-1070.
34. Ouyang XS, Wang X, Lee DT, Tsao SW and Wong YC. (2001). Carcinogenesis, 22, 965-973.
35. Ouyang XS, Wang X, Lee DT, Tsao SW and Wong YC. (2002a). J. Urol., 167, 2598-2602.
36. Ouyang XS, Wang X, Ling MT, Wong HL, Tsao SW and Wong YC. (2002b). Carcinogenesis, 23, 721-725.
37. Palayoor ST, Youmell MY, Calderwood SK, Coleman CN and Price BD. (1999). Oncogene, 18, 7389-7394.
38. Parrinello S, Lin CQ, Murata K, Itahana Y, Singh J, Krtolica A, Campisi J and Desprez PY. (2001). J. Biol. Chem., 276, 39213-39219.
39. Pise-Masison CA, Mahieux R, Jiang H, Ashcroft M, Radonovich M, Duvall J, Guillerm C and Brady JN. (2000). Mol. Cell. Biol., 20, 3377-3386.
40. Polsky D, Young AZ, Busam KJ and Alani RM. (2001). Cancer Res., 61, 6008-6011.
41. Raffo AJ, Kim AL and Fine RL. (2000). Oncogene, 19, 6216-6228.
42. Schindl M, Oberhuber G, Obermair A, Schoppmann SF, Karner B and Birner P. (2001). Cancer Res., 61, 5703-5706.
43. Sevilla L, Zaldumbide A, Pognonec P and Boulukos KE. (2001). Histol. Histopathol., 16, 595-601.
44. Shao J, Fujiwara T, Kadowaki Y, Fukazawa T, Waku T, Itoshima T, Yamatsuji T, Nishizaki M, Roth JA and Tanaka N. (2000). Oncogene, 19, 726-736.
45. Stennicke HR and Salvesen GS. (1997). J. Biol. Chem., 272, 25719-25723.
46. Takai N, Miyazaki T, Fujisawa K, Nasu K and Miyakawa I. (2001). Cancer Lett., 165, 185-193.
47. Tanaka K, Pracyk JB, Takeda K, Yu ZX Ferrans VJ, Desphande SS, Ozaki M, Hwang PM, Lowenstein CJ, Irani K and Finkel T. (1998). J. Biol. Chem., 273, 25922-25928.
48. Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D and Miyamoto S. (1995). Genes Dev., 9, 2723-2735.
49. Wang CY, Mayo MW, Korneluk RG, Goeddel DV and Baldwin Jr AS. (1998). Science, 281, 1680-1683.
50. Wilson JW, Deed RW, Inoue T, Balzi M, Becciolini A, Faraoni P, Potten CS and Norton JD. (2001). Cancer Res., 61, 8803-8810.
51. Wu MX, Ao Z, Prasad KV, Wu R and Schlossman SF. (1998). Science, 281, 998-1001.
52. Zhong H, Voll RE and Ghosh S. (1998). Mol. Cell, 1, 661-671.